Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I) Meeting Abstract


Authors: Lee, E.; Rodon, J.; Demeure, M.; Deming, D.; Federman, N.; McKean, M.; Spira, A.; Kwiatkowski, D.; Hussein, M.; Gordon, E.; Crockett, D.; Ganjoo, K.; Schulte, B.; Cranmer, L.; Schmid, A.; Navarro, W.; Itri, L.; Iyer, G.
Abstract Title: Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I)
Meeting Title: Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer (54th Annual Meeting)
Journal Title: Gynecologic Oncology
Volume: 176
Issue: Suppl. 1
Meeting Dates: 2023 Mar 25-28
Meeting Location: Tampa, FL
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 2023-09-01
Start Page: S185
Language: English
ACCESSION: WOS:001079556100293
DOI: 10.1016/j.ygyno.2023.06.204
PROVIDER: wos
Notes: Meeting Abstract: 1300 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gopakumar Vasudeva Iyer
    342 Iyer